カテゴリー： 世界, 医療/バイオ, QYResearch

バソトシンの世界市場インサイト・予測（～2028年）

【英語タイトル】Global Vasotocin Market Insights, Forecast to 2028

QYResearchが出版した調査資料（QY22JLX10514）・商品コード：QY22JLX10514
・発行会社（調査会社）：QYResearch
・発行日：2022年7月（※2025年版があります。お問い合わせください。）
・ページ数：93
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD4,900 ⇒換算￥744,800見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD7,350 ⇒換算￥1,117,200見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD9,800 ⇒換算￥1,489,600見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

COVID-19のパンデミックにより、バソトシンのグローバル市場規模は2022年にUS$xxxと推定され、調査期間中のCAGRはxxx％で、2028年までに再調整された規模はUS$xxxになると予測されています。この医療危機による経済変化を十分に考慮すると、2021年にバソトシンの世界市場のxxx％を占める「95％以上」タイプは、2028年までにUS$xxxの規模になり、パンデミック後の修正xxx％CAGRで成長すると予測されています。一方、「科学研究」セグメントは、この予測期間を通じてxxx％のCAGRに変更されます。
バソトシンの中国市場規模は2021年にUS$xxxと分析されており、米国とヨーロッパの市場規模はそれぞれUS$xxxとUS$xxxです。米国の割合は2021年にxxx％であり、中国とヨーロッパはそれぞれxxx％とxxx％です。中国の割合は2028年にxxx％に達し、対象期間を通じてxxx％のCAGRを記録すると予測されています。日本、韓国、東南アジアはアジアで注目市場であり、今後6年間のCAGRはそれぞれxxx％、xxx％、xxx％になる見通しです。ヨーロッパのバソトシン市場については、ドイツは2028年までにUS$xxxに達すると予測されており、予測期間中のCAGRはxxx％になる見通しです。

バソトシンのグローバル主要企業には、Peptide Institute、Genscript、Abcam、PerkinElmer、Fisher Scientificなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。

バソトシン市場は、種類と用途によって区分されます。世界のバソトシン市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別および用途別の販売量、売上、予測に焦点を当てています。

【種類別セグメント】
95％以上、99％以上

【用途別セグメント】
科学研究、医療、その他

【掲載地域】
北米：アメリカ、カナダ
ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア
中南米：メキシコ、ブラジル、アルゼンチン
中東・アフリカ：トルコ、サウジアラビア、UAE

【目次（一部）】

・調査の範囲
- バソトシン製品概要
- 種類別市場（95％以上、99％以上）
- 用途別市場（科学研究、医療、その他）
- 調査の目的
・エグゼクティブサマリー
- 世界のバソトシン販売量予測2017-2028
- 世界のバソトシン売上予測2017-2028
- バソトシンの地域別販売量
- バソトシンの地域別売上
- 北米市場
- ヨーロッパ市場
- アジア太平洋市場
- 中南米市場
- 中東・アフリカ市場
・メーカーの競争状況
- 主要メーカー別バソトシン販売量
- 主要メーカー別バソトシン売上
- 主要メーカー別バソトシン価格
- 競争状況の分析
- 企業M&A動向
・種類別市場規模（95％以上、99％以上）
- バソトシンの種類別販売量
- バソトシンの種類別売上
- バソトシンの種類別価格
・用途別市場規模（科学研究、医療、その他）
- バソトシンの用途別販売量
- バソトシンの用途別売上
- バソトシンの用途別価格
・北米市場
- 北米のバソトシン市場規模（種類別、用途別）
- 主要国別のバソトシン市場規模（アメリカ、カナダ）
・ヨーロッパ市場
- ヨーロッパのバソトシン市場規模（種類別、用途別）
- 主要国別のバソトシン市場規模（ドイツ、フランス、イギリス、イタリア、ロシア）
・アジア太平洋市場
- アジア太平洋のバソトシン市場規模（種類別、用途別）
- 主要国別のバソトシン市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア）
・中南米市場
- 中南米のバソトシン市場規模（種類別、用途別）
- 主要国別のバソトシン市場規模（メキシコ、ブラジル、アルゼンチン）
・中東・アフリカ市場
- 中東・アフリカのバソトシン市場規模（種類別、用途別）
- 主要国別のバソトシン市場規模（トルコ、サウジアラビア）
・企業情報
Peptide Institute、Genscript、Abcam、PerkinElmer、Fisher Scientific
・産業チェーン及び販売チャネル分析
- バソトシンの産業チェーン分析
- バソトシンの原材料
- バソトシンの生産プロセス
- バソトシンの販売及びマーケティング
- バソトシンの主要顧客
・マーケットドライバー、機会、課題、リスク要因分析
- バソトシンの産業動向
- バソトシンのマーケットドライバー
- バソトシンの課題
- バソトシンの阻害要因
・主な調査結果

Market Analysis and Insights: Global Vasotocin Market
Due to the COVID-19 pandemic, the global Vasotocin market size is estimated to be worth US$ million in 2022 and is forecast to a readjusted size of US$ million by 2028 with a CAGR of % during the forecast period 2022-2028. Fully considering the economic change by this health crisis, Above 95% accounting for % of the Vasotocin global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR from 2022 to 2028. While Scientific Research segment is altered to an % CAGR throughout this forecast period.
China Vasotocin market size is valued at US$ million in 2021, while the US and Europe Vasotocin are US$ million and US$ million, severally. The proportion of the US is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period 2022-2028. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Vasotocin landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028.
The global key manufacturers of Vasotocin include Peptide Institute, Genscript, Abcam, PerkinElmer and Fisher Scientific, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Global Vasotocin Scope and Segment
Vasotocin market is segmented by Purity and by Application. Players, stakeholders, and other participants in the global Vasotocin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Purity and by Application for the period 2017-2028.
Segment by Purity
Above 95%
Above 99%
Segment by Application
Scientific Research
Medical
Others
By Company
Peptide Institute
Genscript
Abcam
PerkinElmer
Fisher Scientific
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

❖ レポートの目次 ❖

1 Study Coverage
1.1 Vasotocin Product Introduction
1.2 Market by Purity
1.2.1 Global Vasotocin Market Size Growth Rate by Purity, 2017 VS 2021 VS 2028
1.2.2 Above 95%
1.2.3 Above 99%
1.3 Market by Application
1.3.1 Global Vasotocin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Scientific Research
1.3.3 Medical
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Vasotocin Sales Estimates and Forecasts 2017-2028
2.2 Global Vasotocin Revenue Estimates and Forecasts 2017-2028
2.3 Global Vasotocin Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Vasotocin Sales by Region
2.4.1 Global Vasotocin Sales by Region (2017-2022)
2.4.2 Global Sales Vasotocin by Region (2023-2028)
2.5 Global Vasotocin Revenue by Region
2.5.1 Global Vasotocin Revenue by Region (2017-2022)
2.5.2 Global Vasotocin Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Vasotocin Sales by Manufacturers
3.1.1 Global Top Vasotocin Manufacturers by Sales (2017-2022)
3.1.2 Global Vasotocin Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vasotocin in 2021
3.2 Global Vasotocin Revenue by Manufacturers
3.2.1 Global Vasotocin Revenue by Manufacturers (2017-2022)
3.2.2 Global Vasotocin Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Vasotocin Revenue in 2021
3.3 Global Vasotocin Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Vasotocin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Vasotocin Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Purity
4.1 Global Vasotocin Sales by Purity
4.1.1 Global Vasotocin Historical Sales by Purity (2017-2022)
4.1.2 Global Vasotocin Forecasted Sales by Purity (2023-2028)
4.1.3 Global Vasotocin Sales Market Share by Purity (2017-2028)
4.2 Global Vasotocin Revenue by Purity
4.2.1 Global Vasotocin Historical Revenue by Purity (2017-2022)
4.2.2 Global Vasotocin Forecasted Revenue by Purity (2023-2028)
4.2.3 Global Vasotocin Revenue Market Share by Purity (2017-2028)
4.3 Global Vasotocin Price by Purity
4.3.1 Global Vasotocin Price by Purity (2017-2022)
4.3.2 Global Vasotocin Price Forecast by Purity (2023-2028)
5 Market Size by Application
5.1 Global Vasotocin Sales by Application
5.1.1 Global Vasotocin Historical Sales by Application (2017-2022)
5.1.2 Global Vasotocin Forecasted Sales by Application (2023-2028)
5.1.3 Global Vasotocin Sales Market Share by Application (2017-2028)
5.2 Global Vasotocin Revenue by Application
5.2.1 Global Vasotocin Historical Revenue by Application (2017-2022)
5.2.2 Global Vasotocin Forecasted Revenue by Application (2023-2028)
5.2.3 Global Vasotocin Revenue Market Share by Application (2017-2028)
5.3 Global Vasotocin Price by Application
5.3.1 Global Vasotocin Price by Application (2017-2022)
5.3.2 Global Vasotocin Price Forecast by Application (2023-2028)
6 North America
6.1 North America Vasotocin Market Size by Purity
6.1.1 North America Vasotocin Sales by Purity (2017-2028)
6.1.2 North America Vasotocin Revenue by Purity (2017-2028)
6.2 North America Vasotocin Market Size by Application
6.2.1 North America Vasotocin Sales by Application (2017-2028)
6.2.2 North America Vasotocin Revenue by Application (2017-2028)
6.3 North America Vasotocin Market Size by Country
6.3.1 North America Vasotocin Sales by Country (2017-2028)
6.3.2 North America Vasotocin Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Vasotocin Market Size by Purity
7.1.1 Europe Vasotocin Sales by Purity (2017-2028)
7.1.2 Europe Vasotocin Revenue by Purity (2017-2028)
7.2 Europe Vasotocin Market Size by Application
7.2.1 Europe Vasotocin Sales by Application (2017-2028)
7.2.2 Europe Vasotocin Revenue by Application (2017-2028)
7.3 Europe Vasotocin Market Size by Country
7.3.1 Europe Vasotocin Sales by Country (2017-2028)
7.3.2 Europe Vasotocin Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Vasotocin Market Size by Purity
8.1.1 Asia Pacific Vasotocin Sales by Purity (2017-2028)
8.1.2 Asia Pacific Vasotocin Revenue by Purity (2017-2028)
8.2 Asia Pacific Vasotocin Market Size by Application
8.2.1 Asia Pacific Vasotocin Sales by Application (2017-2028)
8.2.2 Asia Pacific Vasotocin Revenue by Application (2017-2028)
8.3 Asia Pacific Vasotocin Market Size by Region
8.3.1 Asia Pacific Vasotocin Sales by Region (2017-2028)
8.3.2 Asia Pacific Vasotocin Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Vasotocin Market Size by Purity
9.1.1 Latin America Vasotocin Sales by Purity (2017-2028)
9.1.2 Latin America Vasotocin Revenue by Purity (2017-2028)
9.2 Latin America Vasotocin Market Size by Application
9.2.1 Latin America Vasotocin Sales by Application (2017-2028)
9.2.2 Latin America Vasotocin Revenue by Application (2017-2028)
9.3 Latin America Vasotocin Market Size by Country
9.3.1 Latin America Vasotocin Sales by Country (2017-2028)
9.3.2 Latin America Vasotocin Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Vasotocin Market Size by Purity
10.1.1 Middle East and Africa Vasotocin Sales by Purity (2017-2028)
10.1.2 Middle East and Africa Vasotocin Revenue by Purity (2017-2028)
10.2 Middle East and Africa Vasotocin Market Size by Application
10.2.1 Middle East and Africa Vasotocin Sales by Application (2017-2028)
10.2.2 Middle East and Africa Vasotocin Revenue by Application (2017-2028)
10.3 Middle East and Africa Vasotocin Market Size by Country
10.3.1 Middle East and Africa Vasotocin Sales by Country (2017-2028)
10.3.2 Middle East and Africa Vasotocin Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Peptide Institute
11.1.1 Peptide Institute Corporation Information
11.1.2 Peptide Institute Overview
11.1.3 Peptide Institute Vasotocin Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Peptide Institute Vasotocin Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Peptide Institute Recent Developments
11.2 Genscript
11.2.1 Genscript Corporation Information
11.2.2 Genscript Overview
11.2.3 Genscript Vasotocin Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Genscript Vasotocin Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Genscript Recent Developments
11.3 Abcam
11.3.1 Abcam Corporation Information
11.3.2 Abcam Overview
11.3.3 Abcam Vasotocin Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Abcam Vasotocin Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Abcam Recent Developments
11.4 PerkinElmer
11.4.1 PerkinElmer Corporation Information
11.4.2 PerkinElmer Overview
11.4.3 PerkinElmer Vasotocin Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 PerkinElmer Vasotocin Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 PerkinElmer Recent Developments
11.5 Fisher Scientific
11.5.1 Fisher Scientific Corporation Information
11.5.2 Fisher Scientific Overview
11.5.3 Fisher Scientific Vasotocin Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Fisher Scientific Vasotocin Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Fisher Scientific Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Vasotocin Industry Chain Analysis
12.2 Vasotocin Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Vasotocin Production Mode & Process
12.4 Vasotocin Sales and Marketing
12.4.1 Vasotocin Sales Channels
12.4.2 Vasotocin Distributors
12.5 Vasotocin Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Vasotocin Industry Trends
13.2 Vasotocin Market Drivers
13.3 Vasotocin Market Challenges
13.4 Vasotocin Market Restraints
14 Key Findings in The Global Vasotocin Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Global Vasotocin Market Size Growth Rate by Purity, 2017 VS 2021 VS 2028 (US$ Million)
Table 2. Major Manufacturers of Above 95%
Table 3. Major Manufacturers of Above 99%
Table 4. Global Vasotocin Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
Table 5. Global Vasotocin Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
Table 6. Global Vasotocin Sales by Region (2017-2022) & (K Units)
Table 7. Global Vasotocin Sales Market Share by Region (2017-2022)
Table 8. Global Vasotocin Sales by Region (2023-2028) & (K Units)
Table 9. Global Vasotocin Sales Market Share by Region (2023-2028)
Table 10. Global Vasotocin Revenue by Region (2017-2022) & (US$ Million)
Table 11. Global Vasotocin Revenue Market Share by Region (2017-2022)
Table 12. Global Vasotocin Revenue by Region (2023-2028) & (US$ Million)
Table 13. Global Vasotocin Revenue Market Share by Region (2023-2028)
Table 14. Global Vasotocin Sales by Manufacturers (2017-2022) & (K Units)
Table 15. Global Vasotocin Sales Share by Manufacturers (2017-2022)
Table 16. Global Vasotocin Revenue by Manufacturers (2017-2022) & (US$ Million)
Table 17. Global Vasotocin Revenue Share by Manufacturers (2017-2022)
Table 18. Vasotocin Price by Manufacturers (2017-2022) &(US$/Unit)
Table 19. Global Vasotocin Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 20. Global Vasotocin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vasotocin as of 2021)
Table 21. Vasotocin Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Vasotocin Product Offered
Table 23. Date of Manufacturers Enter into Vasotocin Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Vasotocin Sales by Purity (2017-2022) & (K Units)
Table 26. Global Vasotocin Sales by Purity (2023-2028) & (K Units)
Table 27. Global Vasotocin Sales Share by Purity (2017-2022)
Table 28. Global Vasotocin Sales Share by Purity (2023-2028)
Table 29. Global Vasotocin Revenue by Purity (2017-2022) & (US$ Million)
Table 30. Global Vasotocin Revenue by Purity (2023-2028) & (US$ Million)
Table 31. Global Vasotocin Revenue Share by Purity (2017-2022)
Table 32. Global Vasotocin Revenue Share by Purity (2023-2028)
Table 33. Vasotocin Price by Purity (2017-2022) & (US$/Unit)
Table 34. Global Vasotocin Price Forecast by Purity (2023-2028) & (US$/Unit)
Table 35. Global Vasotocin Sales by Application (2017-2022) & (K Units)
Table 36. Global Vasotocin Sales by Application (2023-2028) & (K Units)
Table 37. Global Vasotocin Sales Share by Application (2017-2022)
Table 38. Global Vasotocin Sales Share by Application (2023-2028)
Table 39. Global Vasotocin Revenue by Application (2017-2022) & (US$ Million)
Table 40. Global Vasotocin Revenue by Application (2023-2028) & (US$ Million)
Table 41. Global Vasotocin Revenue Share by Application (2017-2022)
Table 42. Global Vasotocin Revenue Share by Application (2023-2028)
Table 43. Vasotocin Price by Application (2017-2022) & (US$/Unit)
Table 44. Global Vasotocin Price Forecast by Application (2023-2028) & (US$/Unit)
Table 45. North America Vasotocin Sales by Purity (2017-2022) & (K Units)
Table 46. North America Vasotocin Sales by Purity (2023-2028) & (K Units)
Table 47. North America Vasotocin Revenue by Purity (2017-2022) & (US$ Million)
Table 48. North America Vasotocin Revenue by Purity (2023-2028) & (US$ Million)
Table 49. North America Vasotocin Sales by Application (2017-2022) & (K Units)
Table 50. North America Vasotocin Sales by Application (2023-2028) & (K Units)
Table 51. North America Vasotocin Revenue by Application (2017-2022) & (US$ Million)
Table 52. North America Vasotocin Revenue by Application (2023-2028) & (US$ Million)
Table 53. North America Vasotocin Sales by Country (2017-2022) & (K Units)
Table 54. North America Vasotocin Sales by Country (2023-2028) & (K Units)
Table 55. North America Vasotocin Revenue by Country (2017-2022) & (US$ Million)
Table 56. North America Vasotocin Revenue by Country (2023-2028) & (US$ Million)
Table 57. Europe Vasotocin Sales by Purity (2017-2022) & (K Units)
Table 58. Europe Vasotocin Sales by Purity (2023-2028) & (K Units)
Table 59. Europe Vasotocin Revenue by Purity (2017-2022) & (US$ Million)
Table 60. Europe Vasotocin Revenue by Purity (2023-2028) & (US$ Million)
Table 61. Europe Vasotocin Sales by Application (2017-2022) & (K Units)
Table 62. Europe Vasotocin Sales by Application (2023-2028) & (K Units)
Table 63. Europe Vasotocin Revenue by Application (2017-2022) & (US$ Million)
Table 64. Europe Vasotocin Revenue by Application (2023-2028) & (US$ Million)
Table 65. Europe Vasotocin Sales by Country (2017-2022) & (K Units)
Table 66. Europe Vasotocin Sales by Country (2023-2028) & (K Units)
Table 67. Europe Vasotocin Revenue by Country (2017-2022) & (US$ Million)
Table 68. Europe Vasotocin Revenue by Country (2023-2028) & (US$ Million)
Table 69. Asia Pacific Vasotocin Sales by Purity (2017-2022) & (K Units)
Table 70. Asia Pacific Vasotocin Sales by Purity (2023-2028) & (K Units)
Table 71. Asia Pacific Vasotocin Revenue by Purity (2017-2022) & (US$ Million)
Table 72. Asia Pacific Vasotocin Revenue by Purity (2023-2028) & (US$ Million)
Table 73. Asia Pacific Vasotocin Sales by Application (2017-2022) & (K Units)
Table 74. Asia Pacific Vasotocin Sales by Application (2023-2028) & (K Units)
Table 75. Asia Pacific Vasotocin Revenue by Application (2017-2022) & (US$ Million)
Table 76. Asia Pacific Vasotocin Revenue by Application (2023-2028) & (US$ Million)
Table 77. Asia Pacific Vasotocin Sales by Region (2017-2022) & (K Units)
Table 78. Asia Pacific Vasotocin Sales by Region (2023-2028) & (K Units)
Table 79. Asia Pacific Vasotocin Revenue by Region (2017-2022) & (US$ Million)
Table 80. Asia Pacific Vasotocin Revenue by Region (2023-2028) & (US$ Million)
Table 81. Latin America Vasotocin Sales by Purity (2017-2022) & (K Units)
Table 82. Latin America Vasotocin Sales by Purity (2023-2028) & (K Units)
Table 83. Latin America Vasotocin Revenue by Purity (2017-2022) & (US$ Million)
Table 84. Latin America Vasotocin Revenue by Purity (2023-2028) & (US$ Million)
Table 85. Latin America Vasotocin Sales by Application (2017-2022) & (K Units)
Table 86. Latin America Vasotocin Sales by Application (2023-2028) & (K Units)
Table 87. Latin America Vasotocin Revenue by Application (2017-2022) & (US$ Million)
Table 88. Latin America Vasotocin Revenue by Application (2023-2028) & (US$ Million)
Table 89. Latin America Vasotocin Sales by Country (2017-2022) & (K Units)
Table 90. Latin America Vasotocin Sales by Country (2023-2028) & (K Units)
Table 91. Latin America Vasotocin Revenue by Country (2017-2022) & (US$ Million)
Table 92. Latin America Vasotocin Revenue by Country (2023-2028) & (US$ Million)
Table 93. Middle East and Africa Vasotocin Sales by Purity (2017-2022) & (K Units)
Table 94. Middle East and Africa Vasotocin Sales by Purity (2023-2028) & (K Units)
Table 95. Middle East and Africa Vasotocin Revenue by Purity (2017-2022) & (US$ Million)
Table 96. Middle East and Africa Vasotocin Revenue by Purity (2023-2028) & (US$ Million)
Table 97. Middle East and Africa Vasotocin Sales by Application (2017-2022) & (K Units)
Table 98. Middle East and Africa Vasotocin Sales by Application (2023-2028) & (K Units)
Table 99. Middle East and Africa Vasotocin Revenue by Application (2017-2022) & (US$ Million)
Table 100. Middle East and Africa Vasotocin Revenue by Application (2023-2028) & (US$ Million)
Table 101. Middle East and Africa Vasotocin Sales by Country (2017-2022) & (K Units)
Table 102. Middle East and Africa Vasotocin Sales by Country (2023-2028) & (K Units)
Table 103. Middle East and Africa Vasotocin Revenue by Country (2017-2022) & (US$ Million)
Table 104. Middle East and Africa Vasotocin Revenue by Country (2023-2028) & (US$ Million)
Table 105. Peptide Institute Corporation Information
Table 106. Peptide Institute Description and Major Businesses
Table 107. Peptide Institute Vasotocin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 108. Peptide Institute Vasotocin Product Model Numbers, Pictures, Descriptions and Specifications
Table 109. Peptide Institute Recent Developments
Table 110. Genscript Corporation Information
Table 111. Genscript Description and Major Businesses
Table 112. Genscript Vasotocin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 113. Genscript Vasotocin Product Model Numbers, Pictures, Descriptions and Specifications
Table 114. Genscript Recent Developments
Table 115. Abcam Corporation Information
Table 116. Abcam Description and Major Businesses
Table 117. Abcam Vasotocin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 118. Abcam Vasotocin Product Model Numbers, Pictures, Descriptions and Specifications
Table 119. Abcam Recent Developments
Table 120. PerkinElmer Corporation Information
Table 121. PerkinElmer Description and Major Businesses
Table 122. PerkinElmer Vasotocin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 123. PerkinElmer Vasotocin Product Model Numbers, Pictures, Descriptions and Specifications
Table 124. PerkinElmer Recent Developments
Table 125. Fisher Scientific Corporation Information
Table 126. Fisher Scientific Description and Major Businesses
Table 127. Fisher Scientific Vasotocin Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2017-2022)
Table 128. Fisher Scientific Vasotocin Product Model Numbers, Pictures, Descriptions and Specifications
Table 129. Fisher Scientific Recent Developments
Table 130. Key Raw Materials Lists
Table 131. Raw Materials Key Suppliers Lists
Table 132. Vasotocin Distributors List
Table 133. Vasotocin Customers List
Table 134. Vasotocin Market Trends
Table 135. Vasotocin Market Drivers
Table 136. Vasotocin Market Challenges
Table 137. Vasotocin Market Restraints
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. Vasotocin Product Picture
Figure 3. Global Vasotocin Market Share by Purity in 2021 & 2028
Figure 3. Above 95% Product Picture
Figure 4. Above 99% Product Picture
Figure 5. Global Vasotocin Market Share by Application in 2021 & 2028
Figure 6. Scientific Research
Figure 7. Medical
Figure 8. Others
Figure 9. Vasotocin Report Years Considered
Figure 10. Global Vasotocin Sales 2017-2028 (K Units)
Figure 11. Global Vasotocin Revenue, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Vasotocin Revenue 2017-2028 (US$ Million)
Figure 13. Global Vasotocin Revenue Market Share by Region in Percentage: 2021 Versus 2028
Figure 14. Global Vasotocin Sales Market Share by Region (2017-2022)
Figure 15. Global Vasotocin Sales Market Share by Region (2023-2028)
Figure 16. North America Vasotocin Sales YoY (2017-2028) & (K Units)
Figure 17. North America Vasotocin Revenue YoY (2017-2028) & (US$ Million)
Figure 18. Europe Vasotocin Sales YoY (2017-2028) & (K Units)
Figure 19. Europe Vasotocin Revenue YoY (2017-2028) & (US$ Million)
Figure 20. Asia-Pacific Vasotocin Sales YoY (2017-2028) & (K Units)
Figure 21. Asia-Pacific Vasotocin Revenue YoY (2017-2028) & (US$ Million)
Figure 22. Latin America Vasotocin Sales YoY (2017-2028) & (K Units)
Figure 23. Latin America Vasotocin Revenue YoY (2017-2028) & (US$ Million)
Figure 24. Middle East & Africa Vasotocin Sales YoY (2017-2028) & (K Units)
Figure 25. Middle East & Africa Vasotocin Revenue YoY (2017-2028) & (US$ Million)
Figure 26. The Vasotocin Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
Figure 27. The Top 5 and 10 Largest Manufacturers of Vasotocin in the World: Market Share by Vasotocin Revenue in 2021
Figure 28. Global Vasotocin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
Figure 29. Global Vasotocin Sales Market Share by Purity (2017-2028)
Figure 30. Global Vasotocin Revenue Market Share by Purity (2017-2028)
Figure 31. Global Vasotocin Sales Market Share by Application (2017-2028)
Figure 32. Global Vasotocin Revenue Market Share by Application (2017-2028)
Figure 33. North America Vasotocin Sales Market Share by Purity (2017-2028)
Figure 34. North America Vasotocin Revenue Market Share by Purity (2017-2028)
Figure 35. North America Vasotocin Sales Market Share by Application (2017-2028)
Figure 36. North America Vasotocin Revenue Market Share by Application (2017-2028)
Figure 37. North America Vasotocin Sales Share by Country (2017-2028)
Figure 38. North America Vasotocin Revenue Share by Country (2017-2028)
Figure 39. United States Vasotocin Revenue (2017-2028) & (US$ Million)
Figure 40. Canada Vasotocin Revenue (2017-2028) & (US$ Million)
Figure 41. Europe Vasotocin Sales Market Share by Purity (2017-2028)
Figure 42. Europe Vasotocin Revenue Market Share by Purity (2017-2028)
Figure 43. Europe Vasotocin Sales Market Share by Application (2017-2028)
Figure 44. Europe Vasotocin Revenue Market Share by Application (2017-2028)
Figure 45. Europe Vasotocin Sales Share by Country (2017-2028)
Figure 46. Europe Vasotocin Revenue Share by Country (2017-2028)
Figure 47. Germany Vasotocin Revenue (2017-2028) & (US$ Million)
Figure 48. France Vasotocin Revenue (2017-2028) & (US$ Million)
Figure 49. U.K. Vasotocin Revenue (2017-2028) & (US$ Million)
Figure 50. Italy Vasotocin Revenue (2017-2028) & (US$ Million)
Figure 51. Russia Vasotocin Revenue (2017-2028) & (US$ Million)
Figure 52. Asia Pacific Vasotocin Sales Market Share by Purity (2017-2028)
Figure 53. Asia Pacific Vasotocin Revenue Market Share by Purity (2017-2028)
Figure 54. Asia Pacific Vasotocin Sales Market Share by Application (2017-2028)
Figure 55. Asia Pacific Vasotocin Revenue Market Share by Application (2017-2028)
Figure 56. Asia Pacific Vasotocin Sales Share by Region (2017-2028)
Figure 57. Asia Pacific Vasotocin Revenue Share by Region (2017-2028)
Figure 58. China Vasotocin Revenue (2017-2028) & (US$ Million)
Figure 59. Japan Vasotocin Revenue (2017-2028) & (US$ Million)
Figure 60. South Korea Vasotocin Revenue (2017-2028) & (US$ Million)
Figure 61. India Vasotocin Revenue (2017-2028) & (US$ Million)
Figure 62. Australia Vasotocin Revenue (2017-2028) & (US$ Million)
Figure 63. China Taiwan Vasotocin Revenue (2017-2028) & (US$ Million)
Figure 64. Indonesia Vasotocin Revenue (2017-2028) & (US$ Million)
Figure 65. Thailand Vasotocin Revenue (2017-2028) & (US$ Million)
Figure 66. Malaysia Vasotocin Revenue (2017-2028) & (US$ Million)
Figure 67. Latin America Vasotocin Sales Market Share by Purity (2017-2028)
Figure 68. Latin America Vasotocin Revenue Market Share by Purity (2017-2028)
Figure 69. Latin America Vasotocin Sales Market Share by Application (2017-2028)
Figure 70. Latin America Vasotocin Revenue Market Share by Application (2017-2028)
Figure 71. Latin America Vasotocin Sales Share by Country (2017-2028)
Figure 72. Latin America Vasotocin Revenue Share by Country (2017-2028)
Figure 73. Mexico Vasotocin Revenue (2017-2028) & (US$ Million)
Figure 74. Brazil Vasotocin Revenue (2017-2028) & (US$ Million)
Figure 75. Argentina Vasotocin Revenue (2017-2028) & (US$ Million)
Figure 76. Middle East and Africa Vasotocin Sales Market Share by Purity (2017-2028)
Figure 77. Middle East and Africa Vasotocin Revenue Market Share by Purity (2017-2028)
Figure 78. Middle East and Africa Vasotocin Sales Market Share by Application (2017-2028)
Figure 79. Middle East and Africa Vasotocin Revenue Market Share by Application (2017-2028)
Figure 80. Middle East and Africa Vasotocin Sales Share by Country (2017-2028)
Figure 81. Middle East and Africa Vasotocin Revenue Share by Country (2017-2028)
Figure 82. Turkey Vasotocin Revenue (2017-2028) & (US$ Million)
Figure 83. Saudi Arabia Vasotocin Revenue (2017-2028) & (US$ Million)
Figure 84. UAE Vasotocin Revenue (2017-2028) & (US$ Million)
Figure 85. Vasotocin Value Chain
Figure 86. Vasotocin Production Process
Figure 87. Channels of Distribution
Figure 88. Distributors Profiles
Figure 89. Bottom-up and Top-down Approaches for This Report
Figure 90. Data Triangulation
Figure 91. Key Executives Interviewed


★調査レポート[バソトシンの世界市場インサイト・予測（～2028年）] (コード：QY22JLX10514)販売に関する免責事項を必ずご確認ください。
★調査レポート[バソトシンの世界市場インサイト・予測（～2028年）]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 高純度アルキル化剤の世界市場インサイト・予測（～2028年）
  • 高純度リドカインの世界市場インサイト・予測（～2028年）
  • アジュバントペプチドの世界市場インサイト・予測（～2028年）
  • フィサレミンの世界市場インサイト・予測（～2028年）
  • 血清胸腺因子の世界市場インサイト・予測（～2028年）

    • ◆H&Iグローバルリサーチのお客様（例）◆